371 related articles for article (PubMed ID: 12716486)
1. Incidence of autoantibodies against type I and type II interferons in a cohort of systemic lupus erythematosus patients in Slovakia.
Slavikova M; Schmeisser H; Kontsekova E; Mateicka F; Borecky L; Kontsek P
J Interferon Cytokine Res; 2003 Mar; 23(3):143-7. PubMed ID: 12716486
[TBL] [Abstract][Full Text] [Related]
2. Anti-interferon autoantibodies in autoimmune polyendocrinopathy syndrome type 1.
Meager A; Visvalingam K; Peterson P; Möll K; Murumägi A; Krohn K; Eskelin P; Perheentupa J; Husebye E; Kadota Y; Willcox N
PLoS Med; 2006 Jul; 3(7):e289. PubMed ID: 16784312
[TBL] [Abstract][Full Text] [Related]
3. Characterization of Type-I IFN subtype autoantibodies and activity in SLE serum and urine.
Harris BD; Kuruganti S; Deshpande A; Goepfert PA; Chatham WW; Walter MR
Lupus; 2020 Aug; 29(9):1095-1105. PubMed ID: 32611267
[TBL] [Abstract][Full Text] [Related]
4. High levels of circulating interferons type I, type II and type III associate with distinct clinical features of active systemic lupus erythematosus.
Oke V; Gunnarsson I; Dorschner J; Eketjäll S; Zickert A; Niewold TB; Svenungsson E
Arthritis Res Ther; 2019 Apr; 21(1):107. PubMed ID: 31036046
[TBL] [Abstract][Full Text] [Related]
5. Increased binding of circulating systemic lupus erythematosus autoantibodies to recombinant interferon alpha 2b.
Khan WA; Qureshi JA
APMIS; 2015 Dec; 123(12):1016-24. PubMed ID: 26547367
[TBL] [Abstract][Full Text] [Related]
6. Lower disease activity but higher risk of severe COVID-19 and herpes zoster in patients with systemic lupus erythematosus with pre-existing autoantibodies neutralising IFN-α.
Mathian A; Breillat P; Dorgham K; Bastard P; Charre C; Lhote R; Quentric P; Moyon Q; Mariaggi AA; Mouries-Martin S; Mellot C; Anna F; Haroche J; Cohen-Aubart F; Sterlin D; Zahr N; Gervais A; Le Voyer T; Bizien L; Amiot Q; Pha M; Hié M; Chasset F; Yssel H; Miyara M; Charneau P; Ghillani-Dalbin P; Casanova JL; Rozenberg F; Amoura Z; Gorochov G
Ann Rheum Dis; 2022 Dec; 81(12):1695-1703. PubMed ID: 35973806
[TBL] [Abstract][Full Text] [Related]
7. Antibody against chromatin assembly factor-1 is a novel autoantibody specifically recognized in systemic lupus erythematosus.
Doe K; Nozawa K; Hiruma K; Yamada Y; Matsuki Y; Nakano S; Ogasawara M; Nakano H; Ikeda T; Ikegami T; Fujishiro M; Kawasaki M; Ikeda K; Amano H; Morimoto S; Ogawa H; Takamori K; Sekigawa I; Takasaki Y
Lupus; 2014 Sep; 23(10):1031-41. PubMed ID: 24836587
[TBL] [Abstract][Full Text] [Related]
8. Anti-cytokine autoantibodies in autoimmunity: preponderance of neutralizing autoantibodies against interferon-alpha, interferon-omega and interleukin-12 in patients with thymoma and/or myasthenia gravis.
Meager A; Wadhwa M; Dilger P; Bird C; Thorpe R; Newsom-Davis J; Willcox N
Clin Exp Immunol; 2003 Apr; 132(1):128-36. PubMed ID: 12653847
[TBL] [Abstract][Full Text] [Related]
9. Circulating interferon-α2 levels are increased in the majority of patients with systemic lupus erythematosus and are associated with disease activity and multiple cytokine activation.
Becker-Merok A; Østli-Eilersten G; Lester S; Nossent J
Lupus; 2013 Feb; 22(2):155-63. PubMed ID: 23213068
[TBL] [Abstract][Full Text] [Related]
10. Altered type II interferon precedes autoantibody accrual and elevated type I interferon activity prior to systemic lupus erythematosus classification.
Munroe ME; Lu R; Zhao YD; Fife DA; Robertson JM; Guthridge JM; Niewold TB; Tsokos GC; Keith MP; Harley JB; James JA
Ann Rheum Dis; 2016 Nov; 75(11):2014-2021. PubMed ID: 27088255
[TBL] [Abstract][Full Text] [Related]
11. Functional assay of type I interferon in systemic lupus erythematosus plasma and association with anti-RNA binding protein autoantibodies.
Hua J; Kirou K; Lee C; Crow MK
Arthritis Rheum; 2006 Jun; 54(6):1906-16. PubMed ID: 16736505
[TBL] [Abstract][Full Text] [Related]
12. Autoantibodies to crude human leucocyte interferon (IFN), native human IFN, recombinant human IFN-alpha 2b and human IFN-gamma in healthy blood donors.
Ross C; Hansen MB; Schyberg T; Berg K
Clin Exp Immunol; 1990 Oct; 82(1):57-62. PubMed ID: 2119920
[TBL] [Abstract][Full Text] [Related]
13. [Peripheral blood mRNA and interferon gene expression in systemic lupus erythematosus].
Tang JP; Gu YY; Shen N; Qian J; Chen XX; Huang XF; Huang XY; Liang D; Guo Q; Yang CD; Bao CD; Chen SL
Zhonghua Nei Ke Za Zhi; 2005 Feb; 44(2):106-10. PubMed ID: 15840221
[TBL] [Abstract][Full Text] [Related]
14. Detection of anti-interferon antibodies in systemic lupus erythematosus.
Suit BE; Axelrod D; Moutsopoulos HM; Decker JL; Hooks JJ
Clin Exp Rheumatol; 1983; 1(2):133-5. PubMed ID: 6442634
[TBL] [Abstract][Full Text] [Related]
15. Higher activation of the interferon-gamma signaling pathway in systemic lupus erythematosus patients with a high type I IFN score: relation to disease activity.
Liu M; Liu J; Hao S; Wu P; Zhang X; Xiao Y; Jiang G; Huang X
Clin Rheumatol; 2018 Oct; 37(10):2675-2684. PubMed ID: 29774490
[TBL] [Abstract][Full Text] [Related]
16. Autoantibody-Positive Healthy Individuals Display Unique Immune Profiles That May Regulate Autoimmunity.
Slight-Webb S; Lu R; Ritterhouse LL; Munroe ME; Maecker HT; Fathman CG; Utz PJ; Merrill JT; Guthridge JM; James JA
Arthritis Rheumatol; 2016 Oct; 68(10):2492-502. PubMed ID: 27059145
[TBL] [Abstract][Full Text] [Related]
17. Systematic identification of novel SLE related autoantibodies responsible for type I IFN production in human plasmacytoid dendritic cells.
Kassim SH; Jordan J; Schreiter J; Adhikarakunnathu S; Baribaud F; San Mateo L
Cell Immunol; 2013; 284(1-2):119-28. PubMed ID: 23973875
[TBL] [Abstract][Full Text] [Related]
18. Antigenic structure of human interferon omega 1 (interferon alpha II1): comparison with other human interferons.
Adolf GR
J Gen Virol; 1987 Jun; 68 ( Pt 6)():1669-76. PubMed ID: 2438379
[TBL] [Abstract][Full Text] [Related]
19. IFN-λ1 with Th17 axis cytokines and IFN-α define different subsets in systemic lupus erythematosus (SLE).
Oke V; Brauner S; Larsson A; Gustafsson J; Zickert A; Gunnarsson I; Svenungsson E
Arthritis Res Ther; 2017 Jun; 19(1):139. PubMed ID: 28619037
[TBL] [Abstract][Full Text] [Related]
20. Alpha-actinin-binding antibodies in relation to systemic lupus erythematosus and lupus nephritis.
Becker-Merok A; Kalaaji M; Haugbro K; Nikolaisen C; Nilsen K; Rekvig OP; Nossent JC
Arthritis Res Ther; 2006; 8(6):R162. PubMed ID: 17062137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
